Interview with Biopact CEO Kurt Swogger
This past Thursday we sat down with Kurt Swogger, CEO and co-founder of Biopact CT for an in-depth interview. If you are a current investor in the company,
This guide is brought to you by Equifund, LLC.
If you have money saved in a retirement account – like 401k, 403b, IRA, or Roth IRA – your investment options are likely restricted to things like stocks, bonds, and mutual funds.
But according to ProPublica, wealthy Americans have been using their retirement accounts to invest in Pre-IPO investments to create a tax advantaged fortune!
The most notable example being the founder of PayPal – and now billionaire venture capitalist – Peter Thiel.
According to the same ProPublica article Thiel started a Roth IRA in 1999 with assets that at the time were worth less than $2,000. Those assets are now valued at $5 billion.
How did he do it?
It all has to do with this little-known account that “unlocks” your retirement assets.
For the full details, read our free guide called Pre-IPO Retirement Accounts: How to Invest in Pre-IPO Investments With a Self-Directed IRA
Yours for investing equality,
Jordan Gillissie – CEO
Equifund
This past Thursday we sat down with Kurt Swogger, CEO and co-founder of Biopact CT for an in-depth interview. If you are a current investor in the company,
Earlier this week we sat down with the CEO of Mivium, Eric Tsai, a semiconductor material science company developing proprietary technology to produce high-purity gallium
Earlier this week we sat down with the management team of Pytheas Energy The call is about 1 hour 15 minutes long and packed with
What’s the #1 thing professional investors have that amateurs don’t?
A written down policy that guides their investment decisions. Why? Because professionals want to see as many investment opportunities as possible. But in order to separate the “good” from the “not good,” they need to define what makes the cut (and what doesn’t.
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.
Over 20 patents have been issued to protect the company's technologies.
Just received FDA clearance for their next-generation KG2 spinal fusion technology.
The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO
Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:
We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.
Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.
If you have not received the email in 5 minutes, please click here to have it resent.
Questions? Our customer service team is always here to help – 1-866-338-3004